Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Codexis Inc (NASDAQ:CDXS)

5.40
Delayed Data
As of 2:40pm ET
 -0.10 / -1.82%
Today’s Change
3.60
Today|||52-Week Range
5.70
+17.39%
Year-to-Date
SECTOR
Process Industries
INDUSTRY
Chemicals: Specialty
MARKET CAP
$264.9M

Company Description

Codexis, Inc. is a protein engineering company, which applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The company discovers, develops and sells proteins that deliver value to its clients in a growing set of industries. It provides state-of-the-art enzyme optimization services and developing biocatalyst products. The company's technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. It offers enzyme optimization and supply, from small scale through to commercial quantities. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Contact Information

Codexis, Inc.
200 Penobscot Drive
Redwood City California 94063-4718
P:(650) 421-8100
Investor Relations:

Employees

Shareholders

Individual stakeholders45.13%
Other institutional28.31%
Mutual fund holders16.05%

Top Executives

John J. NicolsPresident, Chief Executive Officer & Director
Gordon T. SangsterChief Financial Officer & Senior Vice President
Jim LalondeSenior Vice President-Research & Development
Michael Douglas Arthur AldridgeSenior VP-Corporate & Strategic Development